Loading the company…
Loading the company…
Families: Lumbar fusion, Cervical fusion & disc arthroplasty, SI joint fusion.
All companies · Product and company coverage
In the last ten years FDA made 15 decisions for Nexxt Spine (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 3 procedure families, the most in 2020 (7). The latest was on 2025-03-14.
| Family | Decisions on record |
|---|---|
| Lumbar fusion | 15 |
| Cervical fusion & disc arthroplasty | 9 |
| SI joint fusion | 1 |
In 2025, Nexxt Spine reported engagement with 114 surgeons and other clinicians in the states MedaRep covers, worth $166K in consulting, speaking, meals and travel for its device products, the most in Arizona ($32K to 6). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Arizona ($32K, 6 engaged), Florida ($31K, 13 engaged), North Carolina ($23K, 3 engaged), Texas ($22K, 14 engaged), California ($15K, 11 engaged).
| NEXXT MATRIXX Stand Alone ALIF System |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Nexxt Spine.